Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News PharmaTher Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

Healthcare Biotechnology psychedelics
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:PHRM)

PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise

Newsfile 2 days ago

PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program

Newsfile November 17, 2025

PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale

Newsfile October 17, 2025

PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson's Disease

Newsfile October 16, 2025

PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings

Newsfile October 15, 2025

CSE Bulletin: MOC Eligibility Update

Newsfile October 9, 2025

PharmaTher Provides Update on Ketamine Program for LID-Parkinson's Disease

Newsfile October 8, 2025

PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy

GlobeNewswire October 2, 2025

PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments

GlobeNewswire October 1, 2025
View More News ››

Opinion & Analysis (CSE:PHRM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:PHRM)

RE:RE:RE:Why

Keep staying bitter
StockReco - 9 days ago

RE:RE:Why

stocretrograde: Another keyboard whak trying to one up himself with brutal mischaracter? Like a putz? You bet!!!! ...pg
polygraph46 - October 25, 2025

RE:RE:Why

Itistoo: Thank you for those observations..pg
polygraph46 - October 25, 2025

RE:Why

No offense, but I think you aren't sharp enough to observe and probably easily gullible... The company sold it's only revenue...
StockReco - October 25, 2025

RE:Why

It's "hammered into the ground" because of a massive shareholder selloff due to the atrocious deal they made selling their...
Itistoo - October 24, 2025

Why

I've never owned this play but have kept an eye on it. Why has the share price been hammered into the ground? The ketamine news...
polygraph46 - October 24, 2025
View more Bullboard ››

Osisko Development Corp.

Osisko Development Corp.

Osisko Development Corp., together with its subsidiaries, acquires, explores, and develops precious metals resource ...
View More »